As the insulin pump market moves toward the artificial pancreas era, growth is accelerating, and competition is increasing. For a snapshot of the of the space, check out the infographic below. And for a more in-depth look at the market, go to our Meddevicetracker report, "Diabetes Management: Insulin Pumps Market."
Market Snapshot: Global Insulin Pumps Market Eyes Nearly 10% Growth By 2022
The worldwide insulin pumps market is expected to reach more than $4.5bn by 2022, a CAGR of nearly 10%. This market is largely driven by the rising prevalence of diabetes and the need to control spiraling health-care costs associated with diabetes-related complications. While Medtronic's MiniMed 670G dominates the market, Informa's MedDeviceTracker expects Medtronic will see rising competition from innovative start-ups.
More from Business
More from Medtech Insight
• By
International device regulatory group IMDRF has issued a new playbook on “regulatory reliance,” which allows regulators to make use of assessments performed by trusted regulatory partners. The document is the first to offer a detailed guide on developing and implementing these agreements.
• By
Egg Medical is ramping up efforts to expand international sales of its EggNest scatter radiation protection system to shield X-ray procedure room staff without disrupting workflow. Medtech Insight sat down with Bob Wilson, Egg Medical’s CEO, to discuss the various EggNest systems, marketing opportunities and the competitive landscape.
• By
A concealed blunt-tip needle that can be inserted into the heart's pericardial space to treat cardiac arrhythmias has received FDA clearance, providing an alternative to catheter-based methods.